Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene.
Cooper-Knock J, Zhang S, Kenna KP, Moll T, Franklin JP, Allen S, Nezhad HG, Iacoangeli A, Yacovzada NY, Eitan C, Hornstein E, Elhaik E, Celadova P, Bose D, Farhan S, Fishilevich S, Lancet D, Morrison KE, Shaw CE, Al-Chalabi A; Project MinE ALS Sequencing Consortium; Veldink JH, Kirby J, Snyder MP, Shaw PJ.
Cooper-Knock J, et al. Among authors: zhang s.
Cell Rep. 2021 Feb 2;34(5):108730. doi: 10.1016/j.celrep.2021.108730.
Cell Rep. 2021.
PMID: 33535055
Free PMC article.
No abstract available.